Case Study Chemplus

Between 2001 and 2011, the average patient’s out-of-pocket (OOP) cost for brand-name prescriptions rose by more than 80% (Tungol, et al., 2012, p. 691). The increasing OOP costs have contributed to a decrease

Drug coverage is also a significant cost to both Medicaid and Medicare. This recommendation reduces costs specifically in Medicaid and Medicate Part D (Federal Deficit fit with Health Care, 2017. The prescription drug benefit, known as Part D, subsidizes drug cost and has had an estimated 13% increase in premiums since 2016. These rising costs must be mitigated and requiring drug manufacturers to pay the same rebate currently paid to Medicaid and Medicare is the first step. Rebates are paid quarterly to the states and shared with the federal government to offset the overall cost. Implementing this recommendation is estimated to reduce federal government costs by $220

Furthermore, with the pharma logical treatments included in this article for the treatment of Type 2 Diabetes, many individuals will be prevented from developing CVD complications. Studies have shown the importance of patients being compliant with treatment leading to positive health outcomes. With the continued care given to these patients with Type 2 Diabetes many are able to have healthier lifestyles

When a student graduates with a general bachelor’s degree in the United States of America, the average starting annual salary is $50,556. Of this $50,556, 11 percent of the gross pay is taken out for federal taxes, 4 percent is taken out for state income taxes, 6.2 percent is taken out for social security, and 1.45 percent is taken out for Medicare costs. Using the average college graduate’s starting salary, these deductions add up to $11,451.38, leaving an estimated annual net income of $39,104.62. This net income is then used for savings, investments, mortgages, loans, and other daily living expenses crucial to maintaining a certain standard of living in

In conclusion, addressing the problem of non-adherence would help alleviate the burden of added costs to healthcare. When patients take their medications as prescribed, they are considered to be adherent. Adherence has two components that are complementary to each other: persistence and implementation

Medication adherence is described as the extent to which the patients take medication as prescribed by the health care provider. To ensure the patients receive proper care, health care systems must implement procedures to successfully meet their needs and overall improve their quality of life. However, there are several reasons that affect proper medical care, which ultimately results in an increase in health care expenses and poorer health outcomes for patients. Studies have shown that approximately 50% of patients do not take their chronic medications as prescribed and that nonadherence can cost the health care system nearly $100 to $289 billion per year (1). Medication adherence is difficult to achieve due to ineffective communication between

Another topic that is underlined throughout the book was Andie’s non-adherence to her insulin shot and other medications. Throughout the book, Andie has demonstrated many incidences of non-adherence. Andie does not use her needles properly and has intentionally miss insulin shots to lose weight. The reason behind her behavior can be explained by the “Health Belief Model” in the Adherence and Behavior section of PHRM 826 Patient Centered Care. For patients to take action, they need to have high perceived threat from not taking the action. Threat is influenced by severity of non-adherence and susceptibility of those severities. For Andie, she definitely has high perceived severity from knowledge of possible complications of diabetes from

Acquiring or being born with a life-threatening disease is a very expensive experience in the United States. Notably, prices of some of the most popular drugs, like Mylan EpiPens have increased drastically over the last couple years. This can make it extremely difficult for poorer individuals to buy expensive medication, especially if they are not on an already overpriced health insurance plan. The article “Don’t Only Blame Mylan for $600 EpiPens” written by Ezekiel J. Emanuel on September 8, 2016 and published by Fortune Insiders analyzes the recurring high drug prices gouging sick individuals in the United States. Poor competition, patents granted by the United States Patent and Trademark Office and lengthy drug approval processes are leading

Every eighth person in the United States suffers from type 2 diabetes mellitus. According to the CDC, as of 2010 there were 26 million patients with type 2 diabetes mellitus in the U.S. (CDC, 2011). The problem has been increasing despite various proactive and preventive measures developed to reduce its prevalence. In order to promote and ensure compliance, it is important to clearly understand the factors underlying patients’ decisions for noncompliance (Peters, 2012). The existing literature makes substantial contributions to this debate by outlining various factors related to problems of diabetes regimen adherence. Therefore, issues such as demographics, psychological and social factors are of concern, alongside other factors such as medical systems, healthcare providers, and factors related to disease and treatment (Chesanow, 2014).

Medical clerks should consult patients on more affordable healthcare plans while also recommending generic medication over brand name medication. Someone taking three brand-name drugs spends about $1,900 more annually than those who use generic name drugs (ABC News, 2014). In the case of high cholesterol levels, Lipitor is a brand name drug that is often prescribed. Healthcare providers should recommend Atorvastatin, which is the generic brand and is 20-40% cheaper. It is a common myth that brand name drugs are more effective than generic drugs; they have the same active ingredients, but are just made and distributed by different companies. Previous estimates showed that enrollees in the standard Medicare Part D drug plan paid between 42 and 69 percent of their annual drug expenses (Stuart, et al., 2005). Many seniors go without taking the medications they need to maintain

Doing our art in saving lives, we have increased an access to EpiPen by issuing a saving card to users that will effectively cut the cost of two pack EpiPen by $300. In addition, we have doubled the eligibility for patient assistance program, which practically eliminates out of pocket cost for uninsured or underinsured families and

A gap in knowledge exists in the understanding of the influence of risk perception on adherence to treatments related to diabetes. The purpose of this explanatory, descriptive study was to address the perceptions of risk and its relationship with self-care adherence in those with T2DM. This discussion is structured to address the major findings found within the results of the three aims of this study, which were the following:

As a health care provider medication compliance among diabetic patients has been a challenge. Barriers to compliance poses life threatens and poor quality life improvement. Some barriers to compliance: side effects, cultural beliefs, and socioeconomic status. Despite of time consuming in diabetic education; patients will find an excuse for medication non-compliance. Most common patients complain from oral medications is upset stomach, diarrhea, nausea and sometimes emesis. House remedies: some of these patient’s belief that herbals will cure their diabetes. In regards to insulin; some of them express needle phobia. In socioeconomic status is lack of health coverage.

In spite of the wide choice of effective and well-tolerated diabetic treatment large proportion of treated patients, do not achieve satisfactory Glycemic control. Poor therapeutic adherence is a major contributor for insufficient Glycemic control. Only 8.2% of people with diabetes adhere to self-monitoring of blood glucose levels.[4] ( Kim, & Jeong ,2003) Adherence has the largest effect on hyperglycemia.[5] (Brown & Hedges ,2004)The term adherence might imply a more holistic view about self-care than compliance because it places the patient in a central position.[6] (Toljamo & Hentinen,2001). Studies on adherence in patients with diabetes indicate that lack of knowledge and management skills are the main contributing factors to non-adherence.

Another study was conducted by (Lowe and Raynor 2000). That looked at the reasons for non-adherence. They sampled a random sample of 161 patients aged 65 years and above with the mean age being 76 years, and the mean number of medicines given was 4. They used a self-report method, participants were seen at their home where they carried out an interview with the use of a structured questionnaire. Questions were asked about the medicines they took, dosage and how regular the dosages were taken. The results presented a difference in 53% of cases.